Viewing nowLyrica Capsule 75 mg (Pregabalin)
Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

MFDS item code 200511057 · Approved 2005.06.14 · Insurance code 073400200
Treatment of neuropathic pain and fibromyalgia; adjunctive treatment of partial-onset seizures
This medicine treats peripheral and central neuropathic pain in adults, and is used adjunctively for partial seizures in epilepsy. It is also effective for the treatment of fibromyalgia. This helps alleviate symptoms of various neurological diseases and improves quality of life.
The total daily dose of this medicine, as pregabalin, is administered orally in 2 divided doses, with or without food. Since this medicine is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function. (See section ‘5. Patients with renal impairment’.) 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: This medicine may be administered at an initial dose of 150 mg per day. Based on each patient's response and tolerability, the dose may be increased to 300 mg per day after 3 to 7 days. If needed, it may subsequently be increased at 7-day intervals up to a maximum of 600 mg per day. 2) Central neuropathic pain Adults: This medicine may be administered at an initial dose of 150 mg per day. Based on each patient's response and tolerability, the dose may be increased to 300 mg per day after 1 week. After an additional week, it may be increased to the target daily dose of 600 mg. If this dose is not tolerated, a dose reduction may be considered. (See section ‘4. Discontinuation’.) 2. Epilepsy Adults: This medicine may be administered at an initial dose of 150 mg per day. Based on each patient's response and tolerability, the dose may be increased to 300 mg per day after 1 week. If needed, it may subsequently be increased at 7-day intervals up to a maximum of 600 mg per day. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg-450 mg per day. The initial dose is 75 mg twice daily (150 mg per day); based on efficacy and tolerability, it may be increased within 1 week to 150 mg twice daily (300 mg per day). For patients who do not experience sufficient benefit at a dose of 300 mg per day, the dose may be increased within 1 week to 225 mg twice daily (450 mg per day). Clinical studies have also been conducted at a dose of 600 mg per day, but there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg per day are not recommended. 4. Discontinuation Based on current clinical experience, if treatment with this medicine is discontinued, it should be withdrawn gradually over at least 1 week. 5. Patients with renal impairment Dose reductions in patients with impaired renal function should be individualized based on creatinine clearance. In addition to the daily dose based on renal function, an immediate supplemental dose should be administered after each 4-hour hemodialysis session. Creatinine clearance (CLcr), (mL/min) ≥60: Starting dose 150 (mg/day), maximum dose 600 (mg/day), BID or TID Creatinine clearance (CLcr), (mL/min) ≥30-<60: Starting dose 75 (mg/day), maximum dose 300 (mg/day), BID or TID Creatinine clearance (CLcr), (mL/min) ≥15-<30: Starting dose 25-50 (mg/day), maximum dose 150 (mg/day), QD or BID Creatinine clearance (CLcr), (mL/min) <15: Starting dose 25 (mg/day), maximum dose 75 (mg/day), QD Additional dose after hemodialysis: 25, 100, single dose b TID = Total daily dose administered in 3 divided doses BID = Total daily dose administered in 2 divided doses QD = Administered once daily a: The total daily dose (mg/day) should be administered in divided doses as specified in the dosing regimen. b: The additional dose refers to a single supplemental dose. 6. Patients with hepatic impairment No dose adjustment is required in patients with hepatic impairment. 8. Older adults (65 years or older) Dose reduction may be necessary in older adults with impaired renal function.
Children under 12 years: Administration is not recommended because there are insufficient safety and efficacy data. Adolescent patients aged 12-17 years: Administration is not recommended because there are insufficient safety and efficacy data.
This medication may increase the risk of suicidal thoughts or behavior, so mood or behavior changes should be closely monitored during treatment. Pregabalin or any component of this drug should not be taken by individuals with allergies. This medication contains lactose and should not be administered to patients with certain genetic lactose intolerance. Diabetic patients may need to adjust their blood sugar control medications due to weight gain. If allergic reactions such as angioedema occur, the medication should be discontinued immediately. Elderly patients may need caution due to a risk of falls from dizziness or drowsiness. Blurred vision or changes in vision may occur and these symptoms may improve after stopping the medication. Withdrawal symptoms such as insomnia, headache, or anxiety may occur when discontinuing the drug, so it is recommended to taper off gradually. Due to the risk of drug abuse, patients with a history of mental illness or drug abuse should use this medication with caution. Patients with impaired renal function may need dose adjustment. Caution is needed for patients with heart disease, and there is an increased risk of central nervous system depression when used in combination with opioid analgesics. Patients with weakened respiratory function or elderly individuals should be careful as there is a risk of severe respiratory depression. In early pregnancy, there is a risk of fetal malformation, so it is advisable for pregnant women to avoid this medication and women of childbearing age should use effective contraception. Breastfeeding women should consider stopping breastfeeding or discontinuing the medication as it can be transferred through breast milk. This drug can cause dizziness and drowsiness, so caution should be exercised when driving or operating dangerous machinery. If severe skin reactions such as skin rash or Stevens-Johnson syndrome occur, stop taking the medication immediately and consult a healthcare professional. In the case of overdose, symptoms such as confusion, drowsiness, and seizures may occur, and immediate medical attention is necessary. Keep out of reach of children, and be cautious as transferring to another container can cause accidents.
suicidal impulses, suicidal behavior, depression, angioedema, facial swelling, perioral edema, upper airway edema, dizziness, drowsiness, loss of consciousness, confusion, mental disorders, blurred vision, vision changes, insomnia, headache, nausea, anxiety, diarrhea, influenza-like syndrome, restlessness, suicidal thoughts, pain, seizures, hyperhidrosis, misuse, abuse, dependence, congestive heart failure, severe respiratory depression, rhinitis, neutropenia, increased appetite, appetite loss, hypoglycemia, confusion, disorientation, irritability, euphoria, decreased libido, depersonalization, paraphilia, restlessness, agitation, mood swings, emotional depression, emotional elevation, difficulty finding appropriate terminology, hallucinations, abnormal dreams, increased libido, panic attacks, inability to inhibit, apathy, ataxia, motor coordination abnormalities, balance disorders, amnesia, attention disorders, memory disorders, tremor, dysarthria, sensory abnormalities, sensory loss, sedation, drowsiness disorder, cognitive impairment, nystagmus, speech disorders, myoclonus, diminished reflexes, movement abnormalities, psychomotor agitation, orthostatic dizziness, hypersensitivity, burning sensation, action tremor, syncope, stupor, decreased motor function, olfactory disturbances, loss of taste, writing disorder, double vision, vertigo, hyperacusis, first-degree AV block, tachycardia, sinus bradycardia, sinus tachycardia, sinus arrhythmia, hypotension, hypertension, flushing, facial flushing, peripheral coldness, dyspnea, nasal bleeding, cough, nasal congestion, rhinitis, snoring, pharyngeal tension, nasal dryness, vomiting, abdominal distension, constipation, dry mouth, bloating, excessive salivation, gastroesophageal reflux disease, oral sensory loss, ascites, dysphagia, pancreatitis, sweating, papular rash, urticaria, sweating, muscle cramps, arthralgia, back pain, limb pain, cervical spasms, joint swelling, myalgia, muscle spasms, neck pain, muscle stiffness, rhabdomyolysis, urinary disorders, urinary incontinence, reduced urination, renal failure, erectile dysfunction, delayed ejaculation, sexual dysfunction, dysmenorrhea, amenorrhea, mastalgia, breast discharge, gynecomastia, peripheral edema, edema, gait abnormalities, falls, feeling of intoxication, altered sensations, fatigue, chest tightness, generalized edema, pain, fever, chills, weakness, thirst, weight gain, increased alanine aminotransferase, increased serum creatine phosphokinase, increased aspartate aminotransferase, increased blood sugar, decreased platelet count, decreased potassium in the blood, weight loss, increased serum creatinine, decreased white blood cell count, hypersensitivity, allergic reactions, headache, keratitis, pulmonary edema, nausea, diarrhea, tongue swelling, itching, Stevens-Johnson syndrome, toxic epidermal necrolysis, urinary retention, gynecomastia, lethargy, delirium, paralysis (facial paralysis), affective disorder, drowsiness, confused state, agitation, restlessness, worsening of convulsions, gastrointestinal disorders, tinnitus, sleep disorders, skin disorders, increased BUN, blood in stool, colon cancer, gastroenteritis, pneumonia, respiratory failure, coma, death
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 15 degrees Celsius and 30 degrees Celsius. Doing so will help maintain the drug's effectiveness.
A hard capsule with a reddish-brown upper part and a white lower part containing white powder that is white or pale yellow.
30 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Yuyoung Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.